Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 2
2002 14
2003 12
2004 19
2005 10
2006 12
2007 18
2008 15
2009 16
2010 10
2011 22
2012 18
2013 21
2014 19
2015 14
2016 7
2017 8
2018 10
2019 10
2020 9
2021 7
2022 5
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

241 results

Results by year

Filters applied: . Clear all
Page 1
Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer.
Chi KN, Agarwal N, Bjartell A, Chung BH, Pereira de Santana Gomes AJ, Given R, Juárez Soto Á, Merseburger AS, Özgüroğlu M, Uemura H, Ye D, Deprince K, Naini V, Li J, Cheng S, Yu MK, Zhang K, Larsen JS, McCarthy S, Chowdhury S; TITAN Investigators. Chi KN, et al. N Engl J Med. 2019 Jul 4;381(1):13-24. doi: 10.1056/NEJMoa1903307. Epub 2019 May 31. N Engl J Med. 2019. PMID: 31150574 Free article. Clinical Trial.
Randomized Phase III Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients with Muscle-invasive Bladder Cancer. Analysis of the GETUG/AFU V05 VESPER Trial Secondary Endpoints: Chemotherapy Toxicity and Pathological Responses.
Pfister C, Gravis G, Fléchon A, Soulié M, Guy L, Laguerre B, Mottet N, Joly F, Allory Y, Harter V, Culine S; VESPER Trial Investigators. Pfister C, et al. Among authors: guy l. Eur Urol. 2021 Feb;79(2):214-221. doi: 10.1016/j.eururo.2020.08.024. Epub 2020 Aug 28. Eur Urol. 2021. PMID: 32868138 Clinical Trial.
Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma.
Méjean A, Ravaud A, Thezenas S, Colas S, Beauval JB, Bensalah K, Geoffrois L, Thiery-Vuillemin A, Cormier L, Lang H, Guy L, Gravis G, Rolland F, Linassier C, Lechevallier E, Beisland C, Aitchison M, Oudard S, Patard JJ, Theodore C, Chevreau C, Laguerre B, Hubert J, Gross-Goupil M, Bernhard JC, Albiges L, Timsit MO, Lebret T, Escudier B. Méjean A, et al. Among authors: guy l. N Engl J Med. 2018 Aug 2;379(5):417-427. doi: 10.1056/NEJMoa1803675. Epub 2018 Jun 3. N Engl J Med. 2018. PMID: 29860937 Free article. Clinical Trial.
The Functions of the Demethylase JMJD3 in Cancer.
Sanchez A, Houfaf Khoufaf FZ, Idrissou M, Penault-Llorca F, Bignon YJ, Guy L, Bernard-Gallon D. Sanchez A, et al. Among authors: guy l. Int J Mol Sci. 2021 Jan 19;22(2):968. doi: 10.3390/ijms22020968. Int J Mol Sci. 2021. PMID: 33478063 Free PMC article. Review.
Persistent organic pollutants promote aggressiveness in prostate cancer.
Buñay J, Kossai M, Damon-Soubeyrant C, De Haze A, Saru JP, Trousson A, de Joussineau C, Bouchareb E, Kocer A, Vialat M, Dallel S, Degoul F, Bost F, Clavel S, Penault-Llorca F, Valli MP, Guy L, Matthews J, Renaud Y, Ittmann M, Jones J, Morel L, Lobaccaro JM, Baron S. Buñay J, et al. Among authors: guy l. Oncogene. 2023 Sep;42(38):2854-2867. doi: 10.1038/s41388-023-02788-2. Epub 2023 Aug 17. Oncogene. 2023. PMID: 37587334
Epigenetic modifications in prostate cancer.
Ngollo M, Dagdemir A, Karsli-Ceppioglu S, Judes G, Pajon A, Penault-Llorca F, Boiteux JP, Bignon YJ, Guy L, Bernard-Gallon DJ. Ngollo M, et al. Among authors: guy l. Epigenomics. 2014;6(4):415-26. doi: 10.2217/epi.14.34. Epigenomics. 2014. PMID: 25333850 Review.
[Urothelial tumors].
Irani J, Bernardini S, Bonnal JL, Chauvet B, Colombel M, Davin JL, Laurent G, Lebret T, Maidenberg M, Mazerolles C, Pfister C, Roupret M, Roy C, Rozet F, Saint F, Theodore C. Irani J, et al. Among authors: laurent g. Prog Urol. 2007 Nov;17(6):1065-98. doi: 10.1016/s1166-7087(07)74781-4. Prog Urol. 2007. PMID: 18153988 French. No abstract available.
Oxysterol receptors and their therapeutic applications in cancer conditions.
De Boussac H, Alioui A, Viennois E, Dufour J, Trousson A, Vega A, Guy L, Volle DH, Lobaccaro JM, Baron S. De Boussac H, et al. Among authors: guy l. Expert Opin Ther Targets. 2013 Sep;17(9):1029-38. doi: 10.1517/14728222.2013.820708. Epub 2013 Jul 22. Expert Opin Ther Targets. 2013. PMID: 23875732 Review.
[Anticancer drug adherence].
Despas F, Roche H, Laurent G. Despas F, et al. Among authors: laurent g. Bull Cancer. 2013 May;100(5):473-84. doi: 10.1684/bdc.2013.1738. Bull Cancer. 2013. PMID: 23694959 Review. French.
Artificial intelligence to improve cytology performance in urothelial carcinoma diagnosis: results from validation phase of the French, multicenter, prospective VISIOCYT1 trial.
Lebret T, Paoletti X, Pignot G, Roumiguié M, Colombel M, Savareux L, Verhoest G, Guy L, Rigaud J, De Vergie S, Poinas G, Droupy S, Kleinclauss F, Courtade-Saïdi M, Piaton E, Radulescu C, Rioux-Leclercq N, Kandel-Aznar C, Renaudin K, Cochand-Priollet B, Allory Y, Nivet S, Rouprêt M. Lebret T, et al. Among authors: guy l. World J Urol. 2023 Sep;41(9):2381-2388. doi: 10.1007/s00345-023-04519-4. Epub 2023 Jul 22. World J Urol. 2023. PMID: 37480491 Free PMC article.
241 results